Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Classifica tra le azioni #40984
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Prezzo delle azioni
$0.14967717
Capitalizzazione di mercato
$57.63K
Variazione (1 giorno)
10.00%
Variazione (1 anno)
4.98%
Paese
VG
Scambia CRISM Therapeutics Corporation (CRTX)

Categoria

EPS per CRISM Therapeutics Corporation (CRTX)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di CRISM Therapeutics Corporation, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per CRISM Therapeutics Corporation da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE